Lv61
2240 积分 2023-11-17 加入
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
14天前
已完结
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
15天前
已完结
Treatment of Late-onset Acute Graft-versus-host Disease Following Double Lung Transplantation Using a JAK2 Inhibitor
22天前
已完结
A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management
29天前
已完结
Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms
1个月前
已完结
Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms
1个月前
已完结
SOHO State of the Art Updates and Next Questions | Choosing and Properly Using a JAK Inhibitor in Myelofibrosis
1个月前
已完结
Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis
1个月前
已完结
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells
1个月前
已完结
Safety and efficacy of baricitinib in steroid‐resistant or relapsed immune thrombocytopenia: An open‐label pilot study
1个月前
已完结
皖公网安备34019202002308
